Shareholding disclosure
Nxera Pharma Co., Ltd
Declared position
3.95%
Threshold
Crossed upwards
Timeline
Published
17.01.2026
Transaction
08.01.2026
Voting rights breakdown
Voting rights acquired3.95%
Voting rights sold0%
Below threshold0%
Notice details
CategorySingle shareholder
ExchangeXSWX
Notification ID
ZA01-000000000RJU1
Beneficial owner
Nxera Pharma Co., Ltd
Declared address
Nxera Pharma Co., Ltd., Tokyo, JP
On 8 January 2026, Nxera Pharma Co., Ltd ("Nxera")and Santhera Holding AG ("Santhera") entered into an investment agreement. Under the investment agreement, Nxera acquired from Santhera 533,858 shares in Santhera and, subject to certain exemptions, agreed not to sell these shares during a period of 6 months after closing of the investment agreement (lock-up). Date of transfer of equity securities: within 10 trading days
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open